Antineoplastics/thalidomide: Multiple myeloma extramedullary progression and plasmablastic transformation: 8 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1402, 2012-01, pp. : 10-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antineoplastics/thalidomide: Cryptococcal cerebellitis (first reports with melphalan and thalidomide): case report

By  

Reactions Weekly, Vol. 1, Iss. 1250, 2009-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Thalidomide: Dyspnoea: 8 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1056, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Thalidomide in multiple myeloma

By García-Sanz Ramón  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 195-213

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide in Multiple Myeloma

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 431-440

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide improves response rate, survival in multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite